Hoth Therapeutics Announces Participation at Upcoming Investor Conferences in September

Rhea-AI Summary

Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced its CEO, Robb Knie, will present at three investor conferences in September 2020. These events include the LD 500 Virtual Investor Conference on September 3 at 12:20 p.m. ET, the H.C. Wainwright & Co. 22nd Annual Global Investment Conference on September 16 at 1:30 p.m. ET, and the Sidoti & Company 2020 Fall Virtual Investor Conference on September 23 at 2:30 p.m. ET. Management will also be available for one-on-one meetings with investors during these events.

NEW YORK, Aug. 28, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Chief Executive Officer, Robb Knie, is scheduled to present at the following investor conferences in September:

The LD 500 Virtual Investor Conference
September 3, 2020 at 12:20 p.m. ET
Registration: https://www.webcaster4.com/Webcast/Page/2019/36780 

H.C. Wainwright & Co. 22nd Annual Global Investment Conference 2020
September 16, 2020 at 1:30 p.m. ET
Registration: https://www.meetmax.com/sched/event_61861/investor_login.html?attendee_role_id=INVESTOR  

Sidoti & Company 2020 Fall Virtual Investor Conference
September 23, 2020 at 2:30 p.m. ET
Registration: https://sidoti.meetmax.com/sched/event_63793/conference_register.html?attendee_role_id=SIDOTI_INVESTOR 

Management will be available for 1x1 meetings with investors throughout each event. Please contact your conference representative to schedule a meeting. To stay up to date on upcoming events please check our calendar regularly: https://ir.hoththerapeutics.com/events/category/events/

About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. To learn more, please click here.

Investor Contact:
LR Advisors LLC
Email: investorrelations@hoththerapeutics.com 
www.hoththerapeutics.com
Phone: (678) 570-6791  

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/hoth-therapeutics-announces-participation-at-upcoming-investor-conferences-in-september-301120459.html

SOURCE Hoth Therapeutics, Inc.

FAQ

When is the LD 500 Virtual Investor Conference for Hoth Therapeutics scheduled?

The LD 500 Virtual Investor Conference for Hoth Therapeutics is scheduled for September 3, 2020, at 12:20 p.m. ET.

What are the dates for H.C. Wainwright & Co. 22nd Annual Global Investment Conference?

H.C. Wainwright & Co. 22nd Annual Global Investment Conference will take place on September 16, 2020, at 1:30 p.m. ET.

When will Hoth Therapeutics participate in the Sidoti & Company Fall Virtual Investor Conference?

Hoth Therapeutics will participate in the Sidoti & Company 2020 Fall Virtual Investor Conference on September 23, 2020, at 2:30 p.m. ET.

Where can I find more information about Hoth Therapeutics' investor events?

More information about Hoth Therapeutics' investor events can be found on their official calendar at https://ir.hoththerapeutics.com/events/category/events/.

Who is the CEO of Hoth Therapeutics presenting at the upcoming investor conferences?

The CEO of Hoth Therapeutics presenting at the upcoming investor conferences is Robb Knie.